SO-010Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. (2nd July 2019) - Garralda, E; Fiedler, W; Matos, I; Rolling, C; Kebenko, M; Klinghammer, K; Conte, G; Raspagliesi, F; Habel, B; Baumeister, H; Ochsenreither, S; Zurlo, A